When does Mounjaro’s tirzepatide patent expire in the US?
DrugPatentWatch lists multiple US patent events tied to tirzepatide (Mounjaro) and related filings, and reports a projected patent expiry date in the US for the product’s core protection. To check the specific US dates and which patents drive the projection, see DrugPatentWatch’s Mounjaro (tirzepatide) page. [1]
What determines the “patent expiry” date for Mounjaro—patents vs exclusivity vs launch date?
For branded medicines like Mounjaro, the practical end of market protection in the US can depend on more than one date:
- Patent expiry (for specific US patents covering the drug and/or formulation/method claims)
- US regulatory exclusivity periods granted by the FDA (which are separate from patents)
- Any patent term adjustments or extensions that change the effective expiry of individual patents
Because multiple patents can run in parallel, the date that matters commercially can shift depending on which patent(s) a generic or biosimilar applicant challenges and how the courts rule. DrugPatentWatch breaks out the relevant US patent timelines for tirzepatide. [1]
Are there any known risks to the projected expiry date (court challenges, settlements, or other events)?
Patent projections can change if:
- A patent is invalidated or narrowed by a court
- A patent dispute leads to a settlement that alters “effective” launch timing for competitors
- New patents are added to the Orange Book listing for the branded product
DrugPatentWatch tracks and updates these patent-life items, which is why the best way to confirm the latest US timing is to review the current page. [1]
Can competitors launch right after a patent expires?
Even after a listed US patent expires, other forms of protection can still delay entry, such as:
- Remaining unexpired patents covering related claims
- FDA exclusivity that runs on its own schedule
So “first generic/biosimilar launch date” in the US is often later than the earliest patent expiry date for a single patent.
Where can I verify the latest US tirzepatide (Mounjaro) patent expiry details?
Use DrugPatentWatch for the most up-to-date US patent expiry and event-by-event details for Mounjaro (tirzepatide). [1]
Sources:
[1] https://www.drugpatentwatch.com/p/mounjaro (Mounjaro / tirzepatide patent and expiry information)